Erminne Pharmaceuticals LLP
About Erminne Pharmaceuticals LLP
Data last updated:
Erminne Pharmaceuticals LLP is a limited liability partnership (LLP) based in Bangalore South, Karnataka, India. It operates in the commission-based trading segment of the business services sector. It was incorporated on 03 February 2023.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN ABZ-9748. Its GSTIN is 29AAKFE1720D1ZR (Karnataka).
The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners Sreenath Ravi and Nisha Pothanickal Ulahannan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Bangalore South, Karnataka.
The LLP has about 6 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBineeta Plazaa 73, Kasavanahalli Haralur Main Rd, Bangalore South, Karnataka, India – 560102
- IndustryBusiness Services, Commission Trade
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Erminne Pharmaceuticals LLP
Erminne Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenath Ravi | Designated Partner | 03 Feb 2023 | 3 Years 8 Months | Current |
| Nisha Pothanickal Ulahannan | Designated Partner | 03 Feb 2023 | 3 Years 8 Months | Current |
Financials of Erminne Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Erminne Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Erminne Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Erminne Pharmaceuticals are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Erminne Pharmaceuticals LLP
Erminne Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Erminne Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Erminne Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Erminne Pharmaceuticals LLP
Erminne Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAKFE1720D1ZR | Karnataka | Active | 14 Feb 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Erminne Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Erminne Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Erminne Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Erminne Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Erminne Pharmaceuticals LLP
Frequently Asked Questions about Erminne Pharmaceuticals LLP
Erminne Pharmaceuticals is an active limited liability partnership based in Bangalore South, Karnataka, India. The LLP works in commission trade, within the business services industry. It was incorporated on 03 February 2023 (3+ years old) and is registered under LLPIN ABZ-9748.
Erminne Pharmaceuticals has 2 current designated partners:
- Sreenath Ravi - Designated Partner
- Nisha Pothanickal Ulahannan - Designated Partner
The GSTIN of Erminne Pharmaceuticals is 29AAKFE1720D1ZR, registered in Karnataka.
The LLPIN (Limited Liability Partnership Identification Number) of Erminne Pharmaceuticals is ABZ-9748. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Erminne Pharmaceuticals was incorporated on 03 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The registered office of Erminne Pharmaceuticals is at Bineeta Plazaa 73, Kasavanahalli Haralur Main Rd, Bangalore South, Karnataka, India – 560102.
The total obligation of contribution is ₹1 Cr.
Erminne Pharmaceuticals operates in the business services industry, in the commission trade segment.
Erminne Pharmaceuticals has about 6 employees on its provident fund (EPFO) records, the latest count available.